Thermo Electron introduces its rapid mixing accessory that is
designed for use with Thermo's Evolution 300 UV-Vis
spectrophotometer offering scientists reliable and precise
measurement of fast reaction kinetics.
The rapidly growing market for drug discovery outsourcing services
will increase 15 per cent to reach $7bn (€5.5bn) by 2009, fuelled
by the advancing Asian market, according to a new study by Kalorama
Information, publishing division...
The clinical trials industry is struggling to cope with the burden
of maintaining adequate drug accountability documentation for
regulatory compliance.
Dalton Pharma Services has introduced a range of new medicinal
chemistry services that are available to companies involved in drug
discovery that wish to utilise additional scientific and managerial
expertise as well as specialised...
Swiss drugmaker Novartis is celebrating the approval of Exjade in
the EU for the treatment of patients with transfusional iron
overload, hoping for a blockbuster as the drug offers an oral
single daily-dose alternative to cumbersome...
Australia's AtCor Medical will supply an undisclosed US
pharmaceutical company with central blood pressure reading and
clinical trial support services in a deal worth $1.48m (€1.2m).
Researchers gathered in the south of France to discuss how the
pharmaceutical industry can embrace lipid-based drug delivery as a
viable alternative to traditional formulation approaches.
Researchers have developed a new technique that they claim will
vastly speed up the search for new cancer drugs and antibiotics
that has proved problematic and time expensive in the drug's
development cycle.
Chemokine Therapeutics has announced it has received a patent
relating to chemokine analogs for the treatment of human disease,
which includes autoimmune diseases, cancer, cardiovascular disease,
and inflammatory disorders such as...
US blood products and services provider HemaCare has added a new
research segment to the company with the acquisition of private US
firm Teragenix for $4.8m (€3.7m).
Portuguese drug producers are small and need to merge or form
alliances to compete at a global level, investing more in
innovation and increasing their competitiveness like custom
manufacturer Hovione has done, a new report by market...
The market for radiofrequency identification (RFID) tags in
healthcare is set to explode from $90m (€70m) in 2006 to $2.1bn in
2016, driven by the item level tagging of drugs and the growing
appeal of "smart packaging."
Tripos has launched new software that allows scientists to access
and analyse chemical and biological data from a single integrated
desktop discovery environment
After selling a manufacturing plant in Texas to Cardinal Health two
years ago, Adams Respiratory Therapeutics has reacquired the
facility in order to produce its expectorant Mucinex (guaifenesin
extended-release), responding to a...
TNS Healthcare has scooped up a new deal with Pfizer to provide the
drug giant's UK arm with sales and market information in order to
help them achieve their sales objectives.
The battle for the acquisition that will form the world's third
biggest generic drugmaker has intensified, with Iceland's Actavis
making a new offer for Croatian drug manufacturer Pliva that
surpasses that of US pharmaceutical...
Caliper Life Sciences has launched its latest addition to the
company's suite of in vivo imaging systems promising
advanced fluorescent detection capability for accelerating the drug
discovery and development process reducing...
In an attempt to counter competition in generic active
pharmaceutical ingredients (APIs) from Asian manufacturers, BASF
has decided to downscale production at its Minden production site,
implementing a restructuring programme that...
Drug giant Pfizer is claiming victory in defending the world's most
prescribed branded medicine for treating hypertension after a US
court ruled that Dutch drugmaker Synthon's generic copy of Norvasc
(amlodipine besylate)...
The Pharsight Corporation has announced it has entered into the
biggest single project workplan in the company's history utilising
its drug-disease modelling, meta-data analysis and model
visualisation services.
Researchers believe that the discovery of enzymes that play a key
role in building membranes of disease-causing bacteria has ended a
25-year mystery and paves the way for new drug development against
certain types of bacteria.
Drug giant Eli Lilly has joined forces with Suven Life Sciences in
a deal that will focus on pre-clinical research of molecules in the
therapeutic area of central nervous system (CNS) disorders.
Large global contract research organisation, SFBC International,
has changed its name to PharmaNet Development Group in a bid to
make a fresh start and turnaround the troubled business after a
long period of bad press, legal difficulties...
California-based Synteract has scored a clinical trial management
contract from Northwest Biotherapeutics to bring one of the world's
first personalised medicines into a late stage clinical trial.
The recovery that has taken packaging and processing machinery
company IMA to profitability in 2006 has continued, helped by new
opportunities in the biotech sector and a strong growth in
generics.
PPD International has launched a new software system that it claims
can speed up the review time of safety and endpoint-driven data
from large-scale clinical trials or registries.
Seattle drug firm ZymoGenetics has taken Bristol-Myers Squibb (BMS)
to court for infringement of its fusion protein technology patents
by several products, including arthritis medication Orencia
(abatacept).
Bruised by Novartis's snub over a $600m (€466m) vaccine plant,
Maryland has commissioned a study on what more the state can do to
attract a major cell culture vaccine manufacturing facility there.
Germany's Merck has announced its biggest investment in
pharmaceuticals in its 338-year-old history, as its top-selling
oncology drug Erbitux (cetuximab) has driven the company to
allocate €190m for the construction of its first...
PerkinElmer has released its line of gas chromatography products,
which claims to deliver the fastest injection-to-injection time in
conventional gas chromatography, reducing cycle time and increasing
sample throughput.
US generic drugmaker Mylan has agreed to spend around $736m
(€573.4m) to acquire a controlling stake in Matrix, an Indian
manufacturer of active pharmaceutical ingredients (APIs) and solid
oral dosage forms, as relentless competition...
A new report has suggested the US demand for enzymes for
pharmaceutical and biocatalyst sectors will trigger market growth
of 6.9 per cent per year reaching $2.2bn (€1.7bn) in 2010.
Scientists believe they have discovered a novel way in treating
people suffering from anthrax poisoning, which could overcome the
problem of antibiotic resistance that is becoming increasingly
common in southern and Eastern Europe...
In the first drug master file (DMF) approval of its kind, the US
Food and Drug Administration (FDA) has approved the sale of
metformin hydrochloride tablets which are produced by an Indian
company using a pharmaceutical formulation...
The National Institute of Allergy and Infectious Diseases (NIAID)
has awarded Nastech Pharmaceuticals a development grant for RNAi
therapeutics to prevent and treat influenza.
Jacobs Engineering Group has inked a new contract with Boehringer
Ingelheim to provide technical and construction services for its
new bulk active pharmaceutical ingredient (API) facility being
built in Petersburg, Virginia, US.
Canadian contract manufacturer Patheon has teamed up with specialty
pharmaceutical firm Depomed to offer its clients a controlled
release formulation which can grant their drugs increased
bioavailability and less frequent dosing.
Industrial enzyme maker Novozymes is seeking to strengthen its
presence in the biopharmaceutical market by offering to acquire
Australian biotechnology firm Gropep for AUD83.6m (€49.6m), eager
to become a supplier of recombinant ingredients...
Biopharmaceutical firm Altus has asked contract manufacturer Althea
to produce Phase III quantities of a crystallised formulation of
human growth hormone (hGH) which can be administered subcutaneously
weekly instead of daily.
UK drug discovery company, Peakdale Molecular, has introduced its
collection of drug-like molecules targeted towards specific
receptor families achieving drug selectivity to modulate
therapeutically relevant signalling pathways.
Researchers have identified a protein that is thought to defend the
intestinal against microbial invaders offering new insights into
how the intestine fends off pathogens and potentially leading to
new inflammatory bowel disease medications.
Evotec and CHDI have formed a strategic partnership, which aims to
research and develop treatments for Huntington Disease (HD), a
genetic disorder that causes programmed degeneration of brain cells
and loss of intellectual faculties.
Charles River Laboratories becomes the ninth contract research
organisation (CRO) to open up a new pathology facility within the
Chicago Technology Park (CTP), reinforcing the emerging outsourcing
trend in pharmaceutical discovery...
Thermo Electron has reported an operating profit growth of 26 per
cent to $143.2m (€111.2m) and boosted its profit margin by three
percentage points to 20 per cent in its second quarter results.
Fisher Scientific has reported a second-quarter pre-tax profit jump
of 31 per cent to $146.1m (€113.4m), reflecting the success of
recent acquisitions and operating initiatives.
Difficulties in identifying tablets have emerged as a major issue
in a recent US survey of 150 pharmacists who are warning drugmakers
that the lack of distinct appearance in pills leads in dispensing
errors that cost more than 7,000...
Contract research organisations (CROs) are slashing clinical trial
times by an average of 30 per cent and the outsourcing trend is
showing no signs of slowing, as the pharma industry continues to
face rising pressure to reduce time-to-market...
Looking for $45m (€35m) in savings, Teva has decided to abandon its
drug manufacturing plant in Cidra, Puerto Rico, as it scrambles to
adjust capacity seven months after its acquisition of Ivax.